Anlotinib Active Not Recruiting Phase 1 Trials for Malignancies Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02752516A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics